Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit

Published: Wednesday, March 13, 2013
Last Updated: Wednesday, March 13, 2013
Bookmark and Share
Genedata Expressionist will be demonstrated as a platform for automating and standardizing protein characterization that helps eliminate data analysis bottlenecks

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, has announced that Genedata Expressionist® for Mass Spectrometry will be showcased in the "Establishing Analytical Support for Manufacturing" session of the 2013 Biotherapeutics Analytical Summit. The session will present workflows for analyzing glycosylation events using Genedata Expressionist. The Genedata platform automates and standardizes protein characterization within a single high-throughput system to significantly improve sample throughput and result reproducibility. The presentation will be given on March 13 (Royal Sonesta Harbor Court) by Dr. Monica Lane from Genzyme.
 
Genedata Expressionist for Mass Spectrometry is a comprehensive, enterprise software solution that efficiently manages, processes and analyzes massive amounts of mass spectrometry data. With a proven track record of success in the biopharmaceutical industry, it analyzes mass spectrometry data for a variety of tasks related to protein characterization, such as identification and quantification of Post Translational Modifications (PTMs). Instrument-agnostic, Genedata Expressionist integrates and analyzes raw data from any mass spectrometry technology and vendor, serving as an integration platform for analytical labs using a variety of mass spectrometry instruments. By automating routine data analysis, Genedata Expressionist has been successfully applied along the biopharmaceutical R&D and manufacturing pipelines to improve quality control and sample analytics.
 
Standardized Platform Accelerates Research - Reduces Research Costs
Thriving on large experimental data sets, Genedata Expressionist has been proven to reduce data analysis time from weeks to a few hours. By enhancing productivity, improving data quality and accelerating time-to-market, Genedata Expressionist contributes to significant cost savings by several orders of magnitude.
 
The Genedata session at the Biotherapeutics Analytical Summit will demonstrate how leading pharmaceutical companies have successfully automated the analysis of mass spectrometry data for site-specific glycosylation of biopharmaceuticals. The qualitative and quantitative analysis of glycosylation presents data analysis challenges, which Genedata Expressionist solves with a platform for fast comparability of biotherapeutic batches, ensuring consistent manufacturing processes.
 
"Genedata Expressionist for Mass Spectrometry provides our customers with a highly valuable platform that automates the processing of mass spec data in the context of characterizing biotherapeutics," noted Dr. Othmar Pfannes, CEO of Genedata. "In particular, our solution's innovative visualizations enable quick and reproducible decision making. The elimination of data analysis bottlenecks generates tremendous cost and time savings, making Genedata Expressionist nothing short of a killer application for the bioanalytics industry," continued Pfannes.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genedata Announces Evotec Selects Genedata Screener
Company has announced that Evotec has selected Genedata Screener® as a data management platform solution for its drug discovery research.
Wednesday, June 29, 2016
Boehringer Ingelheim Chooses Genedata Selector for Cell Line Development and Cell Culture Optimization
Company has announced that the leading pharma company to implement Genedata Selector as its global cell line and genome knowledge management platform.
Thursday, March 10, 2016
Genedata Signs License Agreement with AstraZeneca
Genedata Screener now AstraZeneca’s corporate platform for expediting drug discovery.
Saturday, November 21, 2015
Kymab Implements Genedata Biologics for High-throughput Antibody Discovery
Genedata Biologics™ integrated workflow platform used to increase throughput and automation of Kymab’s transgenic mice-based discovery platforms.
Tuesday, November 17, 2015
Genedata Completes Important Milestone in Collaboration with Bayer Pharma AG
Successful integration of Genedata Profiler™ allows researchers to access, process, analyze and manage petabytes of NGS and other omics data from patients and pre-clinical experiments.
Thursday, September 24, 2015
Merck Serono Chooses Genedata Biologics to Streamline Antibody Discovery Processes
Global deployment of Genedata Biologics across multiple protein therapeutics R&D groups to standardize workflows and improve efficiency.
Thursday, July 23, 2015
Genedata Releases a Breakthrough for Genomic Comparison
Genedata Selector™4.0 provides reference-independent genome sequence comparisons while reducing data processing and analysis time to optimize efficiency and save costs.
Wednesday, July 22, 2015
Genedata Forges Alliance with Intellicyt
Swiss informatics firm Genedata and Intellicyt today announced an alliance to work on cell-based screening in drug discovery.
Thursday, June 18, 2015
Precision Medicine Software Genedata Profiler™ Launched at Bio-IT World
Open, interoperable enterprise platform for patient and compound profiling provides important data management infrastructure for pharma internal R&D processes.
Friday, April 24, 2015
Partner on Innovative Workflow Platform for High-Throughput Cell Line Development
Novel Cell Line Development (CLD) data platform to support the generation and assessment of mammalian production cell lines.
Tuesday, March 17, 2015
Genedata, Bayer Pharma AG Partner on Innovative Workflow Platform for High-Throughput Cell Line Development
Novel Cell Line Development (CLD) data platform to support the generation and assessment of mammalian production cell lines.
Tuesday, March 17, 2015
Genedata Biologics Licensed by Pfizer
Pfizer implements Genedata Biologics to streamline global biopharma R&D processes.
Wednesday, March 04, 2015
Boehringer Ingelheim Selects Genedata Biologics as Antibody Discovery Workflow Platform
Genedata Biologics integrates and streamlines workflows for protein therapeutics R&D groups across multiple Boehringer Ingelheim sites.
Thursday, February 19, 2015
Genedata Highlights Combination Screening and Surface Plasmon Resonance at SLAS 2015
Colloquium and tutorials on Combination Screening and SPR examine Genedata Screener as the platform for all plate-based screening experiments.
Wednesday, February 04, 2015
Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis
Genedata Expressionist® for Genomic Profiling helps Takara Bio to manage, process, and analyze large NGS datasets.
Wednesday, November 05, 2014
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Protein Boosts Rice Yield by 54%
Over-expression of a natural protein in rice plants led to a 54% increase in crop yield and 40% increase in nitrogen-use efficiency.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Soil Nitrogen Age Important for Precision Agriculture
Calculating the age of nitrogen in corn and soybean fields could lead to improved fertilizer application techniques.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!